High-performance liquid chromatographic method for the determination of drotaverine in human plasma and urine. 1993

O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.

A simple and sensitive HPLC method for the determination of drotaverine in human plasma and urine has been developed. Alkalinized plasma or urine was extracted with organic solvent and the basic components in the organic phase were back-extracted into 0.1 M HCl. An aliquot of the aqueous layer was injected onto the column and the eluent was monitored at 254 nm. Separation was performed on a C18-column with 0.02 M sodium dihydrogen phosphate-methanol (30:70, v/v) containing perchlorate ion at pH 3.2 as mobile phase. Drotaverine was well resolved from the plasma constituents and internal standard. An excellent linearity was observed between peak-height ratios and plasma concentrations and the intra- and inter-assay coefficients of variation were always < 10%. The lowest limit of detection (signal-to-noise ratio 3:1) was 6 ng/ml. The method is suitable for therapeutic monitoring and pharmacokinetic studies of drotaverine in humans as well as in animal models.

UI MeSH Term Description Entries
D008297 Male Males
D010208 Papaverine An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. Cerespan,Papaverine Hydrochloride,Pavabid,Pavatym,Hydrochloride, Papaverine
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
October 1984, Journal of pharmaceutical sciences,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
January 1993, Journal of pharmaceutical and biomedical analysis,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
September 1993, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
November 1987, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
May 1985, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
October 1987, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
October 1989, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
June 1990, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
November 1986, Journal of chromatography,
O O Bolaji, and C O Onyeji, and F O Ogungbamila, and F A Ogunbona, and E O Ogunlana
July 1982, Journal of chromatography,
Copied contents to your clipboard!